Surfactant therapy for neonatal respiratory distress syndrome in 2013.

about

Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14+ Monocytes.Surfactant administration via a thin endotracheal catheter during spontaneous breathing in preterm infants.

P2860

Q35899095-69758F6E-3295-4486-87F7-4F198CCC0A44 Q36268039-50B3E7E7-31DD-46FF-8FB3-B1528D6F48CA

P2860

Surfactant therapy for neonatal respiratory distress syndrome in 2013.

Item

http://www.wikidata.org/entity/Q38141083

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Surfactant therapy for neonatal respiratory distress syndrome in 2013.

@en

type

Item

label

Surfactant therapy for neonatal respiratory distress syndrome in 2013.

@en

prefLabel

Surfactant therapy for neonatal respiratory distress syndrome in 2013.

@en

P1476

Surfactant therapy for neonatal respiratory distress syndrome in 2013.

@en

P2093

Christian P Speer

http://www.w3.org/2001/XMLSchema#string

David G Sweet

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis

Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group.

Early surfactant guided by lamellar body counts on gastric aspirate in very preterm infants.

History of surfactant from 1980.

Immunomodulatory properties of surfactant preparations.

Lucinactant for the prevention of respiratory distress syndrome in premature infants.

A follow-up study of preterm infants given budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants.

European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants--2013 update.

Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.

Very Early Surfactant Without Mandatory Ventilation in Premature Infants Treated With Early Continuous Positive Airway Pressure: A Randomized, Controlled Trial

P304

27-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14767058.2013.829695

http://www.w3.org/2001/XMLSchema#string

P478

26 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P50

Henry L Halliday

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24059549

http://www.w3.org/2001/XMLSchema#string

Surfactant therapy for neonatal respiratory distress syndrome in 2013.

about

P2860

P2860

Surfactant therapy for neonatal respiratory distress syndrome in 2013.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698